24.08.2017 16:59:51

DGAP-Stimmrechtsanteile: STADA

DGAP-PVR: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Voting Rights Announcement: STADA Arzneimittel AG
STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

24.08.2017 / 16:59
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany

2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
X Other reason:
Voluntary group notification with threshold triggered at subsidiary level

3. Details of person subject to the notification obligation
Name: City and country of registered office:
Morgan Stanley Wilmington, Delaware
United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Morgan Stanley & Co. International plc

5. Date on which threshold was crossed or reached:
18 Aug 2017

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
total of both in %
(7.a. + 7.b.)
total number of voting rights of issuer
Resulting situation 6.39 % 3.32 % 9.72 % 62,342,440
Previous notification 5.08 % 3.32 % 8.40 % /

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
ISIN absolute in %
  direct
(Sec. 21 WpHG)
indirect
(Sec. 22 WpHG)
direct
(Sec. 21 WpHG)
indirect
(Sec. 22 WpHG)
DE0007251803 0 3,986,136 0.00 % 6.39 %
Total 3,986,136 6.39 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
Call Option From 15.09.2017 to 15.12.2017 at any time 3,000 0.005 %
Right of recall over securities lending agreements at any time at any time 803,843 1.29 %
    Total 806,843 1.29 %

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
Retail Structure Product From 02.02.2067 to 19.06.2067 at any time Cash 45,976 0.07 %
Equity Swap From 15.01.2018 to 11.07.2019 at any time Cash 1,214,970 1.95 %
Put Option From 15.09.2017 to 15.12.2017 at any time Physical 5,000 0.01 %
      Total 1,265,946 2.03 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)
Morgan Stanley % % %
Morgan Stanley Capital Management, LLC % % %
Morgan Stanley Domestic Holdings, Inc. % % %
Morgan Stanley Capital Services LLC % % %
 
Morgan Stanley % % %
Morgan Stanley Capital Management, LLC % % %
Morgan Stanley Domestic Holdings, Inc. % % %
Morgan Stanley & Co. LLC % % %
 
Morgan Stanley % % %
Morgan Stanley International Holdings Inc. % % %
Morgan Stanley International Limited % % %
Morgan Stanley Investments (UK) % % %
Morgan Stanley & Co. International plc 5,22 % % 8,49 %

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:
 



24.08.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Internet: www.stada.de

 
End of News DGAP News Service

603897  24.08.2017 

fncls.ssp?fn=show_t_gif&application_id=603897&application_name=news&site_id=smarthouse

Analysen zu STADAmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!